MedTrace Logo

The Acute Burn ResUscitation Multicenter Prospective Trial

NCT04356859 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 101

Last updated 2026-05-20

No results posted yet for this study

Summary

This is a prospective randomized multi-center study which will compare acute fluid resuscitation using a colloid strategy (LR + 5% Albumin) to a crystalloid strategy (LR alone), in adults with an acute burn involving at least 25% of their total body surface area.

Conditions

  • Burn Injury

Interventions

DRUG

Albumin Human

Addition of albumin during acute resuscitation following burn injury

Sponsors & Collaborators

  • United States Department of Defense

    collaborator FED

  • American Burn Association

    lead OTHER

Principal Investigators

  • David G Greenhalgh, MD · UC Davis Health

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-22
Primary Completion
2025-09-29
Completion
2025-09-29

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04356859 on ClinicalTrials.gov